Navigation Links
Neuralstem Completes $5.25 Million Financing
Date:2/18/2010

ROCKVILLE, Md., Feb. 18 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE AMEX: CUR) announced today that it has raised a total of $5,228,000 since the beginning of the year, comprised of a previously disclosed $1.5 million private placement of 646,551 common shares at $2.32, priced at a 30 percent premium over the market on the closing, and approximately $3.7 million from warrant exercises.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

Neuralstem also is pleased to announce that it received notice from the NYSE Amex that the Company is now in compliance with its listing requirements.

"These funds will help to support the development of our stem cell technology, including our ongoing clinical trial at Emory University," stated Richard Garr, President and CEO of Neuralstem. "We are also pleased that the NYSE Amex has recognized the improvement in Neuralstem's financial position."

About Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases including: Ischemic S
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
2. Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
4. Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference
5. Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
6. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
7. Neuralstem Reports Second Quarter Financial Results and Highlights
8. Neuralstem Fills Key Product Development Position
9. Neuralstem Responds to New StemCells, Inc. Lawsuit
10. Neuralstem Sues StemCells, Inc. Over New Patent
11. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... NJ (PRWEB) April 01, 2015 Earlier ... BioNJ, a vibrant life sciences industry association that represents ... 400 members. , Jonathan Parker, AJO’s Vice President ... Gala Dinner in February, an event that attracted over ... highlights, Don Wright, a 73 year old cancer survivor ...
(Date:3/31/2015)... HOUSTON, TX and VANCOUVER ... or the "Company") (TSX-V: EPI) announced today that it ... in the US an Investigation New Drug ("IND") application ... in prostate cancer patients.  Approval of the IND application ... testing of EPI-506 in the US.  ...
(Date:3/31/2015)... N.J. , March 31, 2015  Bayer ... Broad Institute of Massachusetts Institute of Technology (MIT) ... drug discovery. The goal of this new part ... human genetics to help create new cardiovascular therapies. ... collaboration with the Broad Institute to the area ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 This ... Professors from the top U.S and International Medical Schools ... their latest research on the application of stem cell ... The symposium is organized and funded by the ... nonprofit that has been convening intimate meetings of top ...
Breaking Biology Technology:HR Consulting Firm, A.J. O'Connor Associates Joins BioNJ – The Vibrant 400 Member Strong Life Sciences Industry Association - and Attends its Annual Dinner 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2
... are very proud to,announce that Cotop International has ... reliability, and a global,distribution network contribute to the ... powerful union of innovative leaders dedicated to the ... 1980 Cotop International was the first company in ...
... an antibody,engineering company developing novel antibodies and ... Technology, today announced the,appointment of Dr. Geert ... has,over 20 years of experience in the ... and development. He comes to f-star,from Baxter ...
... Testing Process Says ... American College of Medical Genetics, BETHESDA, Md., Sept. 25 ... home DNA test kits, tests that can,help determine a person,s ... greater availability of genetic tests and,increased Direct-to-Consumer (DTC) advertising, however, ...
Cached Biology Technology:Antibody Engineering Company f-Star Appoints Geert Mudde as Chief Scientific Officer 2Statement on Direct-To-Consumer Genetic Testing 2Statement on Direct-To-Consumer Genetic Testing 3
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
(Date:3/12/2015)... , March 12, 2015 The mascots ... Brenner Children,s Hospital, part of Wake Forest Baptist Medical ... initiative for the 2015 ACC Men,s Basketball Tournament. Young ... with them and getting their autographs. Brenner ... Baptist. It is the only children,s hospital in northwest ...
(Date:3/11/2015)... 2015   The Sync Project™ today ... measure and harness music to improve health. The ... objective measurements of physiology, enabling the study of ... large populations. It is designed for medical and ... rigorous studies and accelerate the discovery of the ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... publisher Springer and Beijing Normal University Press (BNUP) will ... Series. The agreements for the first seven titles of ... Science+Business Media, and Prof. Geng Yang, CEO of BNUP, ... Risk Governance Project (IRG-Project) is supported by both Chinese ...
... WASHINGTON -- A brain study in infant rats ... which could prompt new questions about using the first-line ... Annals of Neurology EarlyView posted online May ... that the anti-epilepsy drug phenobarbital given to rat pups ...
... expecting a demographic explosion in the number of people over the ... expected that 25% of the population will be over the age ... This is a warning call for health authorities and medical ... in age-related chronic diseases such as osteoporosis. In response ...
Cached Biology News:Springer and the Beijing Normal University Press sign agreement on new book series 2Study raises questions about use of anti-epilepsy drugs in newborns 2Study raises questions about use of anti-epilepsy drugs in newborns 3
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
... Incubator is a compact benchtop and ... microprocessor controller with a large display ... agitation speed. Air circulation inside to ... Temperature can be easily calibrated from ...
... --- a cocktail of 3 siRNAs specifically ... our most popular product. The siTrio reagent ... of your target gene when used under ... and confirmation of optimal transfection with one ...
... MULTI-FUN Incubator is a compact ... uses a microprocessor controller with a ... temperature and agitation speed. Air circulation ... the incubator. Temperature can be easily ...
Biology Products: